Missouri continues to lag behind most states in children's health, report finds
Missouri ranked in the bottom third of all states for children's health, according to a report released Monday — due in part to a high rate of child and teen deaths.
The annual Kids Count Data Book from the Annie E. Casey Foundation, which used data from 2023, evaluated all states on four metrics of child well-being: health, economic well-being, education, and family and community.
Missouri ranked near the middle of states for overall child well-being, at 27th out of 50, weighed down by poor performance in health and education.
Missouri's rankings in the four categories were:
13th in economic well-being,
33rd in education,
35th in health
And 25th in family & community.
'Children's health remains an area of concern,' noted a press release Monday from Family and Community Trust, the Missouri-based nonprofit partner to Kids Count.
Only nine states had higher rates of child and teen deaths in 2023 than Missouri, one of the factors considered in the health ranking. (Those were: Mississippi, Louisiana, New Mexico, Alabama, Tennessee, Arkansas, Alaska, Oklahoma and Montana.)
Missouri generally ranks among the states with the highest rate of firearm deaths for kids. Firearms became the leading cause of kids' deaths in the United States in 2020, surpassing car accidents.
While the national average in 2023 was 29 child and teen deaths per 100,000, that number was 37 deaths per 100,000 in Missouri.
The national average rose overall in 2023. The report notes that while covid deaths contributed to the increase, the rise was largely due to rising firearm deaths and drug overdoses, particularly among teens ages 15 to 19.
Also bringing Missouri's health ranking down: Missouri's rate of low-birth weight babies increased in 2023 from 2019 and is above the national average.
Other factors helped Missouri's score. For one, Missouri has seen major improvements in children's insurance coverage since the state implemented Medicaid expansion in 2021. The rate of uninsured kids fell from 7% in 2019 to 5% in 2023, which is now on par with the national average.
Nationally, Missouri saw among the sharpest declines in uninsured people overall from 2019 to 2023 with the expansion of Medicaid.
Those gains could be threatened by Congress' budget proposal to reduce Medicaid spending in part by imposing more barriers to care.
Teen births in the state have gone down, in line with national trends — though the state's average is still above the national one.
The rate of overweight or obese kids has also improved in Missouri and is down to 31% of kids in 2023, on par with the national average.
The rate of kids in poverty declined to 14% in the state in 2023, below the 16% national average.
Missouri's education ranking slipped in recent years.
In 2023, 77% of Missouri eighth graders were not proficient at math, according to the report, which is nearly 10 percentage points worse than 2019 and is worse than the national average.
The press release from Family and Community Trust said the data show a 'continuing need to invest in education in Missouri.'
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
TD Cowen Reiterates Buy Rating on Molina Healthcare (MOH) Stock
Molina Healthcare, Inc. (NYSE:MOH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On July 28, Ryan Langston, an analyst from TD Cowen, reiterated a 'Buy' rating on the company's stock, and the associated price target was lowered to $203.00. The analyst noted that Molina Healthcare, Inc. (NYSE:MOH) continues to effectively manage the medical costs in the challenging environment, mainly in Medicaid, where it is witnessing pressures in behavioral, pharmacy, and inpatient/outpatient care. A doctor in scrubs shaking hands with a patient, representing the healthcare services provided to individuals and families. Molina Healthcare, Inc. (NYSE:MOH) continues to actively work with state partners in order to restore Medicaid rates to appropriate levels. It has considered increased cost trends in the Medicare and Marketplace bids for 2026. Despite challenges, Molina Healthcare, Inc. (NYSE:MOH)'s strategic efforts and adjustments in rate filings reflect growth potential, justifying the analyst's rating. For FY 2025, the Premium revenue is expected to be ~$42 billion, reflecting an increase of ~9% from FY 2024. Molina Healthcare, Inc. (NYSE:MOH) expects its FY 2025 GAAP earnings to be no less than $16.90 per diluted share. Oakmark Funds, advised by Harris Associates, released its Q2 2025 investor letter. Here is what the fund said: 'Molina Healthcare, Inc. (NYSE:MOH) is a leading managed care company. The company is the fourth largest player in managed Medicaid and has consistently delivered industry-leading margins historically. In our view, this is thanks to Molina Healthcare's exceptional management team and culture of operational excellence. Moreover, we think Molina Healthcare has a long runway for growth given its small scale relative to peers and untapped opportunities in their Medicare and Marketplace business segments. Recently, the Medicaid industry has come under substantial pressure due to a challenging redetermination cycle and additional headwinds from legislation under the current administration. This provided the opportunity to, in our view, purchase shares in a best-in-class managed care company at depressed valuation on trough earnings.' While we acknowledge the potential of MOH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Brandi Glanville Details New Treatment for Facial Disfiguration, Reveals If She'd Get Filler Again
Thanks to social media, Brandi Glanville has a new doctor and new treatment in place as her years-long battle with facial disfigurement continues. The 52-year-old Real Housewives of Beverly Hills alum told Us Weekly exclusively that she 'randomly' met New York City-based 'infectious disease doctor' Dr. Michael Scoma online and he's hoping to help. 'He specializes in super hard to treat things where people can't get a diagnosis,' Glanville explained to Us. The first course in her treatment is 'IV antibiotics and fungal medications' through a PICC line in Glanville's arm. Glanville admitted that she's 'a wreck' as her health battle continues but is trying to keep a positive mindset. 'I always joke my life is like The Last of Us? I'm just turning into one of those black mold people,' Glanville said. 'That's how I felt. I have lumps on my face and they're moving around.' What Brandi Glanville Has Said About Her Facial Disfigurement: Treatments, Teeth and Mental Health Glanville told Us it was 'the strangest feeling' to know something was moving around in her face. 'Dr Michael Scoma said he wouldn't know if there was a parasite or not, because he didn't treat me early on. But if there was, it would have been gone by now,' she said. 'A lot of this infection, in this deep tissue — the staph infection, and there's other problems happening — it mimics a parasite. It has this fluid that jumps around your face because it's spreading.'Initially, it was just her face. Now, the infection has spread to Glanville's 'whole' head, neck, shoulder, collarbone and down her left arm. 'I spent two years being told there was really not anything wrong with me,' she explained. Glanville's health issues started when she returned home from Morocco in January 2023 after filming The Real Housewives Ultimate Girls Trip season 4, discovering that she had contracted a parasite. (Glanville left the show after she was accused of sexual misconduct during filming by costar Caroline Manzo, which she has vehemently denied.) 'It's definitely calmed down since I was treated for the parasite, but now I'm left with [an] infection in my skin,' she told Us, noting that 'fluid' often leaks out of her ear and her face is 'all sunken in' — all things she hopes to cure with the help of Dr. Scoma. 'Right now, our focus is on treating Brandi's long-standing infection and its secondary effects,' Scoma told Us exclusively. 'Once the infection is fully controlled and she's stable, we can evaluate any next steps to support her recovery.' Scoma has taken a 'proactive' approach to Glanville's health issues with a 'multi-phase treatment.' The IV antibiotics Glanville discussed with Us are the first step — and only a short-term solution. Scoma eventually plans to give Glanville 'long-term maintenance' via oral antibiotic therapy with 'close monitoring.' He will also make 'adjustments' based on her response. Brandi Glanville Reveals She's Spent Over $113K on Health Issues, Misses 'Living Life' 'We can expect to see meaningful progress within the next few weeks, and I do believe Brandi can make a full recovery,' Scoma added. Glanville must follow Scoma's 'treatment protocols closely' and kick off her healing journey with 'proper rest' and 'a protein rich diet,' he told Us. She also must incorporate 'accessible strategies that support immunological health, like staying hydrated, managing stress, and maintaining key nutrients.' Along with Dr. Scoma, the former reality star also teamed up with 'angel' healthcare strategist Rachel Strauss, who is also known as the PBM Princess, to help with her medical bills. 'She advocates for people who have tons of medical bills. When you're sick and they're piling up, that causes stress and it makes your medical issues worse,' Glanville told Us, revealing that she has 'well over' $130,000 in medical bills. Strauss told Us that she hopes to 'recoup some of [Glanville's] money back' as they work together. 'I don't know that we're gonna be able to wipe a fat $100,000 away, but what we are going to be able to do is make sure that the proper parties who have to pay for those claims pay for them,' she said. 'Where it does fall on her responsibility is working with the hospitals she saw, reviewing what was billed, making sure it was billed properly — because certain things were truly emergencies that doctors will validate — and getting those reduced however we can.' Brandi Glanville Pixie Productions Former 'Real Housewives of Beverly Hills' Stars: Where Are They Now? Glanville has seen 21 doctors (which has led to her medical debt) as she navigates her health issues, and some have blamed her facial disfigurement on 'old filler,' referring to past cosmetic procedures. She also made it clear to Us that there aren't any trips to a plastic surgeon in the near future — but is hoping to get a facelift one day. 'The doctor actually said my skin should regenerate quite a bit — not as much as I would like — because they did dissolve so much,' she shared. 'But it's going to be at least a year before I can do anything cosmetic, and I won't ever get an injection again.' When Dr. Scoma was asked about Glanville potentially getting cosmetic surgery again, he told Us, 'Right now, our focus is on treating Brandi's long-standing infection and its secondary effects. Once the infection is fully controlled and she's stable, we can evaluate any next steps to support her recovery.' Solve the daily Crossword
Yahoo
9 hours ago
- Yahoo
CVS Health Corporation (CVS) Is 'The Last Man Standing,' Says Jim Cramer
We recently published . CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently discussed. CVS Health Corporation (NYSE:CVS) is a pharmaceutical retailer whose shares are among the top performers in the industry. They have gained 55% year-to-date and are up by 16.8% since late July. CVS Health Corporation (NYSE:CVS) has performed well on the stock market as its rivals continue to struggle. In his previous remarks about the firm, Cramer has commented on the competitive dynamics and speculated that the stock could go even higher. Here are his latest comments about CVS Health Corporation (NYSE:CVS): '[On a Baird upgrade] I think that they are the last man standing, with Rite Aid pulling back and Walgreen, they're shutting a huge amount of Walgreen since they were sold. I think that by the way, David Joiner, non-promotional. Did a remarkable job in terms of health insurance. They are the one to bet on if you want to be in that area. I don't want to be in that area after reading Semblest let's just put a gun to my head with five bullets I don't want to go there, just bad ratio.' Previously, Cramer discussed CVS Health Corporation (NYSE:CVS)'s stock price: 'Right, and remember, Walgreens shrinkings, Rite-Aid gone away, 185 million people now go to these, including 60 million people who use two or more of their offerings. David, I've got to tell you, they are, if you remember, the one that was the worst, they're now the first. David Joiner, congratulations, you know how to price your business. And, they're getting out of the individual exchange plans in 2026. Goodbye Medicaid? 'Guidance goes, six, six twenty, from five seventy five, six dollars, there's a stock that going to . . .one hundred dollars!' While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
